D-1 AND D-2 DOPAMINE-RECEPTORS IN PERINATAL AND ADULT BASAL GANGLIA

Citation
Sj. Boyson et Ce. Adams, D-1 AND D-2 DOPAMINE-RECEPTORS IN PERINATAL AND ADULT BASAL GANGLIA, Pediatric research, 41(6), 1997, pp. 822-831
Citations number
43
Categorie Soggetti
Pediatrics
Journal title
ISSN journal
00313998
Volume
41
Issue
6
Year of publication
1997
Pages
822 - 831
Database
ISI
SICI code
0031-3998(1997)41:6<822:DADDIP>2.0.ZU;2-L
Abstract
There is reason to believe that dopamine is important in developmental programs of the basal ganglia, brain nuclei implicated in motor and c ognitive processing. Dopamine exerts effects through dopamine receptor s, which are predominantly of the D-1 and D-2 subtypes in the basal ga nglia. Cocaine acts as a stimulant of dopamine receptors and may cause long-term abnormalities in children exposed in utero. Dopamine recept or (primarily D-1) stimulation has been linked to gene regulation. The refore, D-1 and D-2 receptor densities in perinatal and adult striatum and globus pallidus were examined using quantitative autoradiography. The most striking finding was that pallidal D-1 receptor densities we re 7-15 times greater in the perinatal cases than in the adult. Pallid al D-2 receptor densities were similar at both ages. In both the adult and perinatal striatum, D-2 receptor densities were greater in the pu tamen than in the caudate, and both D-1 and D-2 receptor densities wer e modestly enriched in caudate striosomes compared with the matrix. In both caudate and putamen, perinatal D-1 receptor levels were within t he adult range, whereas D-2 receptor levels were only 50% of adult val ues. The development of D-1 and D-2 receptors appears to vary across t he major subdivisions of the human basal ganglia. The facts that we fo und such extremely high levels of D-1 receptors in the perinatal palli dum, and that D-1 receptor activation influences gene regulation, sugg est that the globus pallidus could be particularly susceptible to long -term changes with perinatal exposure to cocaine and other D-1 recepto r agonists or antagonists.